New derivatives of vitamin B12 show preferential targeting of tumors.
Waibel R, Treichler H, Schaefer NG, van Staveren DR, Mundwiler S, Kunze S, Küenzi M, Alberto R, Nüesch J, Knuth A, Moch H, Schibli R, Schubiger PA.
Waibel R, et al.
Cancer Res. 2008 Apr 15;68(8):2904-11. doi: 10.1158/0008-5472.CAN-07-6771.
Cancer Res. 2008.
PMID: 18413759